
NeurologyLive® Friday 5 — March 6, 2026
Key Takeaways
- Neuro-oncology experts outline diagnostic and management pitfalls in paraneoplastic neurologic syndromes, emphasizing timely recognition in cancer patients across a multi-episode clinical roundtable format.
- Environmental risk assessment in Alzheimer disease is spotlighted through discussion of air pollution associations and the rationale for integrating exposome-focused research into prevention strategies.
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending March 6, 2026.
Welcome to NeurologyLive®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.
Click the read more buttons for more details and information about each highlight.
1: Crossroads in Neuro-Oncology: Understanding Paraneoplastic Neurologic Syndromes
In our latest NeurologyLive Roundtable Discussion video series, neuro-oncology experts Shaliee Shah, MD, and Ditte Primdahl, MD, both of Northwestern, discussed the recognition and management of paraneoplastic neurologic syndromes in patients with cancer across 6 episodes.
2: Understanding the Links Between Air Pollution and Increased Alzheimer Disease Risk
In this recent Q&A, R. Scott Turner, PhD, MD, director of the memory disorders program at MedStar Georgetown University Hospital, discussed the importance of investigating environmental risk factors in Alzheimer disease.
3: The Invisible Workforce That Determines Whether Your Patients Age at Home or in a Hospital Bed
In this latest feature, guest contributor Neal K. Shah, CEO of CareYaya Health Technologies, discusses how the largest workforce in the United States maintains the safety of patients with dementia at home while remaining underpaid and unrecognized.
4: NeuroVoices: Amaal Starling, MD, FAHA, FAAN, on Real-World Insights From the INFUSE Study of Eptinezumab
In our latest NeuroVoices Q&A, Amaal Starling, MD, FAHA, FAAN, an associate professor of neurology at Mayo Clinic, provided a breakdown of the real-world eptinezumab data from INFUSE and its implications for early, robust migraine intervention after CGRP failure.
5: INSIGHT Launches International Effort to Advance Women’s Neurology Education
In this recent Q&A, neurologists Esther Bui, MD, and Angela O'Neal, MD, talked about the INSIGHT network, a collaborative global initiative designed to advance medical education in women’s neurology.

















